Adaptive Biotechnologies Corp. (ADPT)
16.24
-0.18
(-1.10%)
USD |
NASDAQ |
Dec 31, 16:00
16.00
-0.24
(-1.48%)
After-Hours: 20:00
Adaptive Biotechnologies Free Cash Flow: -62.94M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Zymeworks, Inc. | -64.45M |
| Cue Biopharma, Inc. | -29.82M |
| Recursion Pharmaceuticals, Inc. | -450.20M |
| Arcellx, Inc. | -201.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.127M |
| Cash from Investing (Quarterly) | 17.28M |
| Cash from Financing (Quarterly) | 1.684M |
| Free Cash Flow Per Share (Quarterly) | -0.0462 |
| Free Cash Flow to Equity (Quarterly) | -3.242M |
| Free Cash Flow to Firm (Quarterly) | -4.565M |
| Free Cash Flow Yield | -2.53% |